MRGPRX1
ENSG00000170255
Target class
GPCR
Chromosome
11
- Chemical probe available
- Yes
- Other names
- MRGX1
- Target name
- MRGPRX1
- Gene name
- MAS related GPR family member X1
- Gene symbol
- MRGPRX1
- Protein name
- Mas-related G-protein coupled receptor member X1 (Sensory neuron-specific G-protein coupled receptor 3/4)
- Gene biotype
- Protein coding
- Gene family
- G protein-coupled receptors, Class A orphans
- Target class
- GPCR
- Target type
- Human gene
- Tissues expressed in
- 0
- Highest tissue expression
- 0.04
- Tissue specificity (Gini)
- 0.981
- Tissue specificity (tau)
- 1
- KEGG gene identifiers
- hsa:259249
- Protein interaction confidence
- 0.838167
- Protein interaction partners
- 6
- End position
- 18939414
- Start position
- 18933499
- Chromosome
- 11
- Strand
- Reverse
- Cell membrane
- Multi-pass membrane protein .
- PubMed 36302898
- PubMed 37347749
- PubMed 37591889
- Tissue specificity (tau)
- 1
- Expression inequality (Gini)
- 0.981481
Expression in transcripts per million
- Testis
- 0.04
- Lung
- 0
- Pituitary
- 0
- Brain - Frontal Cortex (BA9)
- 0
- Colon - Sigmoid
- 0
Expression in transcripts per million
- Testis0.04
- Lung0
- Pituitary0
- Brain - Frontal Cortex (BA9)0
- Colon - Sigmoid0
- Colon - Transverse0
- Brain - Hypothalamus0
- Esophagus - Mucosa0
- Brain - Anterior cingulate cortex (BA24)0
- Skin - Not Sun Exposed (Suprapubic)0
- Cervix - Endocervix0
- Brain - Cerebellum0
- Brain - Putamen (basal ganglia)0
- Esophagus - Gastroesophageal Junction0
- Brain - Cerebellar Hemisphere0
- Artery - Tibial0
- Skin - Sun Exposed (Lower leg)0
- Small Intestine - Terminal Ileum0
- Adipose - Visceral (Omentum)0
- Liver0
- Spleen0
- Cervix - Ectocervix0
- Brain - Amygdala0
- Nerve - Tibial0
- Artery - Aorta0
And 29 more, listed on the interactive page.
- GO:0007165
- GO:0007166
- GO:0007193
- GO:0007200
- GO:0016477
- GO:0070098
- GO:0160025
- GO:1902349
- GO:1904057
- GO:0005886
- GO:0009986
- GO:0004888
- GO:0004930
- GO:0016493
Related records
Trials (132)
- "Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"
- A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
- A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
- A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
- A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine
- A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer
- A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands
- A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
- A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
- A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria
- Acceptability and Cost Effectiveness of Home Based Management of Fever: Different Strategies
- ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
- Adjuvant Effect of Chloroquine on Gemcitabine
- An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
- Antimalarial Drug Resistance in Mali
- Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
- Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia
- Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria
- Assessing a Risk Model for G6PD Deficiency
- Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)